The Huck Institutes of the Life Sciences

Researchers map druggable genomic targets in evolving malaria parasite

Research collaboration use whole genome analyses and chemogenetics to identify new drug targets and resistance genes in 262 parasite cell lines of Plasmodium falciparum — the protozoan pathogen that causes malaria — that are resistant to 37 diverse antimalarial compounds.